세계의 암 치료용 신규 약물 전달 시스템 시장 2019 : 기업별, 지역별, 종류/용도별, 시장예측

■ 영문 제목 : Global Novel Drug Delivery Systems in Cancer Therapy Market 2019 by Company, Regions, Type and Application, Forecast to 2024

Globalinforesearch가 발행한 조사보고서이며, 코드는 GIR9090580 입니다.■ 상품코드 : GIR9090580
■ 조사/발행회사 : Globalinforesearch
■ 발행일 : 2019년 9월 13일
■ 페이지수 : 119
■ 작성언어 : 영어
■ 보고서 형태 : PDF
■ 납품 방식 : E메일
■ 조사대상 지역 : 글로벌
■ 산업 분야 : 의료, 제약
■ 판매가격 / 옵션 (부가세별도)
Single User (1명 열람용)USD3,480 ⇒환산₩3,897,600견적의뢰/주문/질문
Multi User (5명 열람용)USD5,220 ⇒환산₩5,846,400견적의뢰/주문/질문
Corporate User (동일기업내 공유가능)USD6,960 ⇒환산₩7,795,200견적의뢰/구입/질문
가격옵션 설명
- 지불하실 금액은 상기 원화금액에 부가세(10%)를 더한 금액입니다.
- 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다.
- 지불방법은 계좌이체/무통장입금 또는 카드결제이며, 세금계산서 발행 가능합니다.
본 조사보고서는 암 치료용 신규 약물 전달 시스템의 세계시장에 대해서 조사분석한 자료로서, 암 치료용 신규 약물 전달 시스템의 세계시장 개요, 시장동향, 종류/용도별 시장규모, 지역별 분석 (북미, 유럽, 아시아, 남미, 중동/아프리카), 관련기업 정보등이 포함되어 있습니다.
・세계의 암 치료용 신규 약물 전달 시스템시장동향
・관련기업 개요 (사업개요, 제품종류, 판매동향, 시장점유율)
・주요 지역별 암 치료용 신규 약물 전달 시스템 시장분석/시장규모
  - 북미시장 (미국, 캐나다, 멕시코)
  - 유럽시장 (독일, 영국, 프랑스, 러시아, 이탈리아)
  - 아시아시장 (중국, 일본, 한국, 인도, 동남아시아)
  - 남미시장 (브라질, 아르헨티나, 콜롬비아)
  - 중동/아프리카시장 (사우디아라비아, 터키, 이집트, 나이지리아, 남아프리카)
・암 치료용 신규 약물 전달 시스템의 종류별 시장분석/시장규모
・암 치료용 신규 약물 전달 시스템의 용도별 시장분석/시장규모
・암 치료용 신규 약물 전달 시스템의 세계시장 예측 (지역별 예측, 종류별/용도별 시장예측)
・암 치료용 신규 약물 전달 시스템의 판매채널, 유통업체 분석
...
■ 보고서 개요

Novel Drug delivery System (NDDS) refers to the approaches, formulations, technologies, and systems for transporting a pharmaceutical compound in the body as needed to safely achieve its desired therapeutic effects. NDDS is a system for delivery of drug other than conventional drug delivery system. NDDS is a combination of advance technique and new dosage forms which are far better than conventional dosage forms.

Scope of the Report:
Advantages of Novel Drug Delivery System are: Optimum dose at the right time and right location, efficient use of expensive drugs, excipients and reduction in production cost, Beneficial to patients, better therapy, improved comfort and standard of living.
The global Novel Drug Delivery Systems in Cancer Therapy market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Novel Drug Delivery Systems in Cancer Therapy.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Novel Drug Delivery Systems in Cancer Therapy market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Novel Drug Delivery Systems in Cancer Therapy market by product type and applications/end industries.

Market Segment by Companies, this report covers
Teva
Johnson & Johnson
Roche
Takeda
AbbVie
Samyang Biopharmaceuticals
Celgene
Spectrum Pharmaceuticals, Inc.
Gilead Sciences
Shire (Baxalta)
Merrimack

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Nanoparticles
Liquid Embolics
Embolization Particles

Market Segment by Applications, can be divided into
Hospitals & Clinic
Cancer Treatment Centers
Others

■ 보고서 목차

Table of Contents

1 Novel Drug Delivery Systems in Cancer Therapy Market Overview
1.1 Product Overview and Scope of Novel Drug Delivery Systems in Cancer Therapy
1.2 Classification of Novel Drug Delivery Systems in Cancer Therapy by Types
1.2.1 Global Novel Drug Delivery Systems in Cancer Therapy Revenue Comparison by Types (2019-2024)
1.2.2 Global Novel Drug Delivery Systems in Cancer Therapy Revenue Market Share by Types in 2018
1.2.3 Nanoparticles
1.2.4 Liquid Embolics
1.2.5 Embolization Particles
1.3 Global Novel Drug Delivery Systems in Cancer Therapy Market by Application
1.3.1 Global Novel Drug Delivery Systems in Cancer Therapy Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Hospitals & Clinic
1.3.3 Cancer Treatment Centers
1.3.4 Others
1.4 Global Novel Drug Delivery Systems in Cancer Therapy Market by Regions
1.4.1 Global Novel Drug Delivery Systems in Cancer Therapy Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Novel Drug Delivery Systems in Cancer Therapy Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Novel Drug Delivery Systems in Cancer Therapy Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Novel Drug Delivery Systems in Cancer Therapy Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Novel Drug Delivery Systems in Cancer Therapy Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Novel Drug Delivery Systems in Cancer Therapy Status and Prospect (2014-2024)
1.5 Global Market Size of Novel Drug Delivery Systems in Cancer Therapy (2014-2024)
2 Manufacturers Profiles
2.1 Teva
2.1.1 Business Overview
2.1.2 Novel Drug Delivery Systems in Cancer Therapy Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Teva Novel Drug Delivery Systems in Cancer Therapy Revenue, Gross Margin and Market Share (2017-2018)
2.2 Johnson & Johnson
2.2.1 Business Overview
2.2.2 Novel Drug Delivery Systems in Cancer Therapy Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Johnson & Johnson Novel Drug Delivery Systems in Cancer Therapy Revenue, Gross Margin and Market Share (2017-2018)
2.3 Roche
2.3.1 Business Overview
2.3.2 Novel Drug Delivery Systems in Cancer Therapy Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Roche Novel Drug Delivery Systems in Cancer Therapy Revenue, Gross Margin and Market Share (2017-2018)
2.4 Takeda
2.4.1 Business Overview
2.4.2 Novel Drug Delivery Systems in Cancer Therapy Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Takeda Novel Drug Delivery Systems in Cancer Therapy Revenue, Gross Margin and Market Share (2017-2018)
2.5 AbbVie
2.5.1 Business Overview
2.5.2 Novel Drug Delivery Systems in Cancer Therapy Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 AbbVie Novel Drug Delivery Systems in Cancer Therapy Revenue, Gross Margin and Market Share (2017-2018)
2.6 Samyang Biopharmaceuticals
2.6.1 Business Overview
2.6.2 Novel Drug Delivery Systems in Cancer Therapy Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Samyang Biopharmaceuticals Novel Drug Delivery Systems in Cancer Therapy Revenue, Gross Margin and Market Share (2017-2018)
2.7 Celgene
2.7.1 Business Overview
2.7.2 Novel Drug Delivery Systems in Cancer Therapy Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Celgene Novel Drug Delivery Systems in Cancer Therapy Revenue, Gross Margin and Market Share (2017-2018)
2.8 Spectrum Pharmaceuticals, Inc.
2.8.1 Business Overview
2.8.2 Novel Drug Delivery Systems in Cancer Therapy Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Spectrum Pharmaceuticals, Inc. Novel Drug Delivery Systems in Cancer Therapy Revenue, Gross Margin and Market Share (2017-2018)
2.9 Gilead Sciences
2.9.1 Business Overview
2.9.2 Novel Drug Delivery Systems in Cancer Therapy Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Gilead Sciences Novel Drug Delivery Systems in Cancer Therapy Revenue, Gross Margin and Market Share (2017-2018)
2.10 Shire (Baxalta)
2.10.1 Business Overview
2.10.2 Novel Drug Delivery Systems in Cancer Therapy Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Shire (Baxalta) Novel Drug Delivery Systems in Cancer Therapy Revenue, Gross Margin and Market Share (2017-2018)
2.11 Merrimack
2.11.1 Business Overview
2.11.2 Novel Drug Delivery Systems in Cancer Therapy Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Merrimack Novel Drug Delivery Systems in Cancer Therapy Revenue, Gross Margin and Market Share (2017-2018)
3 Global Novel Drug Delivery Systems in Cancer Therapy Market Competition, by Players
3.1 Global Novel Drug Delivery Systems in Cancer Therapy Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Novel Drug Delivery Systems in Cancer Therapy Players Market Share
3.2.2 Top 10 Novel Drug Delivery Systems in Cancer Therapy Players Market Share
3.3 Market Competition Trend
4 Global Novel Drug Delivery Systems in Cancer Therapy Market Size by Regions
4.1 Global Novel Drug Delivery Systems in Cancer Therapy Revenue and Market Share by Regions
4.2 North America Novel Drug Delivery Systems in Cancer Therapy Revenue and Growth Rate (2014-2019)
4.3 Europe Novel Drug Delivery Systems in Cancer Therapy Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Novel Drug Delivery Systems in Cancer Therapy Revenue and Growth Rate (2014-2019)
4.5 South America Novel Drug Delivery Systems in Cancer Therapy Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Novel Drug Delivery Systems in Cancer Therapy Revenue and Growth Rate (2014-2019)
5 North America Novel Drug Delivery Systems in Cancer Therapy Revenue by Countries
5.1 North America Novel Drug Delivery Systems in Cancer Therapy Revenue by Countries (2014-2019)
5.2 USA Novel Drug Delivery Systems in Cancer Therapy Revenue and Growth Rate (2014-2019)
5.3 Canada Novel Drug Delivery Systems in Cancer Therapy Revenue and Growth Rate (2014-2019)
5.4 Mexico Novel Drug Delivery Systems in Cancer Therapy Revenue and Growth Rate (2014-2019)
6 Europe Novel Drug Delivery Systems in Cancer Therapy Revenue by Countries
6.1 Europe Novel Drug Delivery Systems in Cancer Therapy Revenue by Countries (2014-2019)
6.2 Germany Novel Drug Delivery Systems in Cancer Therapy Revenue and Growth Rate (2014-2019)
6.3 UK Novel Drug Delivery Systems in Cancer Therapy Revenue and Growth Rate (2014-2019)
6.4 France Novel Drug Delivery Systems in Cancer Therapy Revenue and Growth Rate (2014-2019)
6.5 Russia Novel Drug Delivery Systems in Cancer Therapy Revenue and Growth Rate (2014-2019)
6.6 Italy Novel Drug Delivery Systems in Cancer Therapy Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Novel Drug Delivery Systems in Cancer Therapy Revenue by Countries
7.1 Asia-Pacific Novel Drug Delivery Systems in Cancer Therapy Revenue by Countries (2014-2019)
7.2 China Novel Drug Delivery Systems in Cancer Therapy Revenue and Growth Rate (2014-2019)
7.3 Japan Novel Drug Delivery Systems in Cancer Therapy Revenue and Growth Rate (2014-2019)
7.4 Korea Novel Drug Delivery Systems in Cancer Therapy Revenue and Growth Rate (2014-2019)
7.5 India Novel Drug Delivery Systems in Cancer Therapy Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Novel Drug Delivery Systems in Cancer Therapy Revenue and Growth Rate (2014-2019)
8 South America Novel Drug Delivery Systems in Cancer Therapy Revenue by Countries
8.1 South America Novel Drug Delivery Systems in Cancer Therapy Revenue by Countries (2014-2019)
8.2 Brazil Novel Drug Delivery Systems in Cancer Therapy Revenue and Growth Rate (2014-2019)
8.3 Argentina Novel Drug Delivery Systems in Cancer Therapy Revenue and Growth Rate (2014-2019)
8.4 Colombia Novel Drug Delivery Systems in Cancer Therapy Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Novel Drug Delivery Systems in Cancer Therapy by Countries
9.1 Middle East and Africa Novel Drug Delivery Systems in Cancer Therapy Revenue by Countries (2014-2019)
9.2 Saudi Arabia Novel Drug Delivery Systems in Cancer Therapy Revenue and Growth Rate (2014-2019)
9.3 UAE Novel Drug Delivery Systems in Cancer Therapy Revenue and Growth Rate (2014-2019)
9.4 Egypt Novel Drug Delivery Systems in Cancer Therapy Revenue and Growth Rate (2014-2019)
9.5 Nigeria Novel Drug Delivery Systems in Cancer Therapy Revenue and Growth Rate (2014-2019)
9.6 South Africa Novel Drug Delivery Systems in Cancer Therapy Revenue and Growth Rate (2014-2019)
10 Global Novel Drug Delivery Systems in Cancer Therapy Market Segment by Type
10.1 Global Novel Drug Delivery Systems in Cancer Therapy Revenue and Market Share by Type (2014-2019)
10.2 Global Novel Drug Delivery Systems in Cancer Therapy Market Forecast by Type (2019-2024)
10.3 Nanoparticles Revenue Growth Rate (2014-2024)
10.4 Liquid Embolics Revenue Growth Rate (2014-2024)
10.5 Embolization Particles Revenue Growth Rate (2014-2024)
11 Global Novel Drug Delivery Systems in Cancer Therapy Market Segment by Application
11.1 Global Novel Drug Delivery Systems in Cancer Therapy Revenue Market Share by Application (2014-2019)
11.2 Novel Drug Delivery Systems in Cancer Therapy Market Forecast by Application (2019-2024)
11.3 Hospitals & Clinic Revenue Growth (2014-2019)
11.4 Cancer Treatment Centers Revenue Growth (2014-2019)
11.5 Others Revenue Growth (2014-2019)
12 Global Novel Drug Delivery Systems in Cancer Therapy Market Size Forecast (2019-2024)
12.1 Global Novel Drug Delivery Systems in Cancer Therapy Market Size Forecast (2019-2024)
12.2 Global Novel Drug Delivery Systems in Cancer Therapy Market Forecast by Regions (2019-2024)
12.3 North America Novel Drug Delivery Systems in Cancer Therapy Revenue Market Forecast (2019-2024)
12.4 Europe Novel Drug Delivery Systems in Cancer Therapy Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Novel Drug Delivery Systems in Cancer Therapy Revenue Market Forecast (2019-2024)
12.6 South America Novel Drug Delivery Systems in Cancer Therapy Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Novel Drug Delivery Systems in Cancer Therapy Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source

List of Tables and Figures

Figure Novel Drug Delivery Systems in Cancer Therapy Picture
Table Product Specifications of Novel Drug Delivery Systems in Cancer Therapy
Table Global Novel Drug Delivery Systems in Cancer Therapy and Revenue (Million USD) Market Split by Product Type
Figure Global Novel Drug Delivery Systems in Cancer Therapy Revenue Market Share by Types in 2018
Figure Nanoparticles Picture
Figure Liquid Embolics Picture
Figure Embolization Particles Picture
Table Global Novel Drug Delivery Systems in Cancer Therapy Revenue (Million USD) by Application (2014-2024)
Figure Novel Drug Delivery Systems in Cancer Therapy Revenue Market Share by Applications in 2018
Figure Hospitals & Clinic Picture
Figure Cancer Treatment Centers Picture
Figure Others Picture
Table Global Market Novel Drug Delivery Systems in Cancer Therapy Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Novel Drug Delivery Systems in Cancer Therapy Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Novel Drug Delivery Systems in Cancer Therapy Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Novel Drug Delivery Systems in Cancer Therapy Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Novel Drug Delivery Systems in Cancer Therapy Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Novel Drug Delivery Systems in Cancer Therapy Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Novel Drug Delivery Systems in Cancer Therapy Revenue (Million USD) and Growth Rate (2014-2024)
Table Teva Basic Information, Manufacturing Base and Competitors
Table Teva Novel Drug Delivery Systems in Cancer Therapy Type and Applications
Table Teva Novel Drug Delivery Systems in Cancer Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table Johnson & Johnson Novel Drug Delivery Systems in Cancer Therapy Type and Applications
Table Johnson & Johnson Novel Drug Delivery Systems in Cancer Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table Roche Basic Information, Manufacturing Base and Competitors
Table Roche Novel Drug Delivery Systems in Cancer Therapy Type and Applications
Table Roche Novel Drug Delivery Systems in Cancer Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table Takeda Basic Information, Manufacturing Base and Competitors
Table Takeda Novel Drug Delivery Systems in Cancer Therapy Type and Applications
Table Takeda Novel Drug Delivery Systems in Cancer Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table AbbVie Basic Information, Manufacturing Base and Competitors
Table AbbVie Novel Drug Delivery Systems in Cancer Therapy Type and Applications
Table AbbVie Novel Drug Delivery Systems in Cancer Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table Samyang Biopharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Samyang Biopharmaceuticals Novel Drug Delivery Systems in Cancer Therapy Type and Applications
Table Samyang Biopharmaceuticals Novel Drug Delivery Systems in Cancer Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table Celgene Basic Information, Manufacturing Base and Competitors
Table Celgene Novel Drug Delivery Systems in Cancer Therapy Type and Applications
Table Celgene Novel Drug Delivery Systems in Cancer Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table Spectrum Pharmaceuticals, Inc. Basic Information, Manufacturing Base and Competitors
Table Spectrum Pharmaceuticals, Inc. Novel Drug Delivery Systems in Cancer Therapy Type and Applications
Table Spectrum Pharmaceuticals, Inc. Novel Drug Delivery Systems in Cancer Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table Gilead Sciences Basic Information, Manufacturing Base and Competitors
Table Gilead Sciences Novel Drug Delivery Systems in Cancer Therapy Type and Applications
Table Gilead Sciences Novel Drug Delivery Systems in Cancer Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table Shire (Baxalta) Basic Information, Manufacturing Base and Competitors
Table Shire (Baxalta) Novel Drug Delivery Systems in Cancer Therapy Type and Applications
Table Shire (Baxalta) Novel Drug Delivery Systems in Cancer Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table Merrimack Basic Information, Manufacturing Base and Competitors
Table Merrimack Novel Drug Delivery Systems in Cancer Therapy Type and Applications
Table Merrimack Novel Drug Delivery Systems in Cancer Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table Global Novel Drug Delivery Systems in Cancer Therapy Revenue (Million USD) by Players (2014-2019)
Table Global Novel Drug Delivery Systems in Cancer Therapy Revenue Share by Players (2014-2019)
Figure Global Novel Drug Delivery Systems in Cancer Therapy Revenue Share by Players in 2017
Figure Global Novel Drug Delivery Systems in Cancer Therapy Revenue Share by Players in 2018
Figure Global Top 5 Players Novel Drug Delivery Systems in Cancer Therapy Revenue Market Share in 2018
Figure Global Top 10 Players Novel Drug Delivery Systems in Cancer Therapy Revenue Market Share in 2018
Figure Global Novel Drug Delivery Systems in Cancer Therapy Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Novel Drug Delivery Systems in Cancer Therapy Revenue (Million USD) by Regions (2014-2019)
Table Global Novel Drug Delivery Systems in Cancer Therapy Revenue Market Share by Regions (2014-2019)
Figure Global Novel Drug Delivery Systems in Cancer Therapy Revenue Market Share by Regions (2014-2019)
Figure Global Novel Drug Delivery Systems in Cancer Therapy Revenue Market Share by Regions in 2018
Figure North America Novel Drug Delivery Systems in Cancer Therapy Revenue and Growth Rate (2014-2019)
Figure Europe Novel Drug Delivery Systems in Cancer Therapy Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Novel Drug Delivery Systems in Cancer Therapy Revenue and Growth Rate (2014-2019)
Figure South America Novel Drug Delivery Systems in Cancer Therapy Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Novel Drug Delivery Systems in Cancer Therapy Revenue and Growth Rate (2014-2019)
Table North America Novel Drug Delivery Systems in Cancer Therapy Revenue by Countries (2014-2019)
Table North America Novel Drug Delivery Systems in Cancer Therapy Revenue Market Share by Countries (2014-2019)
Figure North America Novel Drug Delivery Systems in Cancer Therapy Revenue Market Share by Countries (2014-2019)
Figure North America Novel Drug Delivery Systems in Cancer Therapy Revenue Market Share by Countries in 2018
Figure USA Novel Drug Delivery Systems in Cancer Therapy Revenue and Growth Rate (2014-2019)
Figure Canada Novel Drug Delivery Systems in Cancer Therapy Revenue and Growth Rate (2014-2019)
Figure Mexico Novel Drug Delivery Systems in Cancer Therapy Revenue and Growth Rate (2014-2019)
Table Europe Novel Drug Delivery Systems in Cancer Therapy Revenue (Million USD) by Countries (2014-2019)
Figure Europe Novel Drug Delivery Systems in Cancer Therapy Revenue Market Share by Countries (2014-2019)
Figure Europe Novel Drug Delivery Systems in Cancer Therapy Revenue Market Share by Countries in 2018
Figure Germany Novel Drug Delivery Systems in Cancer Therapy Revenue and Growth Rate (2014-2019)
Figure UK Novel Drug Delivery Systems in Cancer Therapy Revenue and Growth Rate (2014-2019)
Figure France Novel Drug Delivery Systems in Cancer Therapy Revenue and Growth Rate (2014-2019)
Figure Russia Novel Drug Delivery Systems in Cancer Therapy Revenue and Growth Rate (2014-2019)
Figure Italy Novel Drug Delivery Systems in Cancer Therapy Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Novel Drug Delivery Systems in Cancer Therapy Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Novel Drug Delivery Systems in Cancer Therapy Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Novel Drug Delivery Systems in Cancer Therapy Revenue Market Share by Countries in 2018
Figure China Novel Drug Delivery Systems in Cancer Therapy Revenue and Growth Rate (2014-2019)
Figure Japan Novel Drug Delivery Systems in Cancer Therapy Revenue and Growth Rate (2014-2019)
Figure Korea Novel Drug Delivery Systems in Cancer Therapy Revenue and Growth Rate (2014-2019)
Figure India Novel Drug Delivery Systems in Cancer Therapy Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Novel Drug Delivery Systems in Cancer Therapy Revenue and Growth Rate (2014-2019)
Table South America Novel Drug Delivery Systems in Cancer Therapy Revenue by Countries (2014-2019)
Table South America Novel Drug Delivery Systems in Cancer Therapy Revenue Market Share by Countries (2014-2019)
Figure South America Novel Drug Delivery Systems in Cancer Therapy Revenue Market Share by Countries (2014-2019)
Figure South America Novel Drug Delivery Systems in Cancer Therapy Revenue Market Share by Countries in 2018
Figure Brazil Novel Drug Delivery Systems in Cancer Therapy Revenue and Growth Rate (2014-2019)
Figure Argentina Novel Drug Delivery Systems in Cancer Therapy Revenue and Growth Rate (2014-2019)
Figure Colombia Novel Drug Delivery Systems in Cancer Therapy Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Novel Drug Delivery Systems in Cancer Therapy Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Novel Drug Delivery Systems in Cancer Therapy Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Novel Drug Delivery Systems in Cancer Therapy Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Novel Drug Delivery Systems in Cancer Therapy Revenue Market Share by Countries in 2018
Figure Saudi Arabia Novel Drug Delivery Systems in Cancer Therapy Revenue and Growth Rate (2014-2019)
Figure UAE Novel Drug Delivery Systems in Cancer Therapy Revenue and Growth Rate (2014-2019)
Figure Egypt Novel Drug Delivery Systems in Cancer Therapy Revenue and Growth Rate (2014-2019)
Figure Nigeria Novel Drug Delivery Systems in Cancer Therapy Revenue and Growth Rate (2014-2019)
Figure South Africa Novel Drug Delivery Systems in Cancer Therapy Revenue and Growth Rate (2014-2019)
Table Global Novel Drug Delivery Systems in Cancer Therapy Revenue (Million USD) by Type (2014-2019)
Table Global Novel Drug Delivery Systems in Cancer Therapy Revenue Share by Type (2014-2019)
Figure Global Novel Drug Delivery Systems in Cancer Therapy Revenue Share by Type (2014-2019)
Figure Global Novel Drug Delivery Systems in Cancer Therapy Revenue Share by Type in 2019
Table Global Novel Drug Delivery Systems in Cancer Therapy Revenue Forecast by Type (2019-2024)
Figure Global Novel Drug Delivery Systems in Cancer Therapy Market Share Forecast by Type (2019-2024)
Figure Global Nanoparticles Revenue Growth Rate (2014-2019)
Figure Global Liquid Embolics Revenue Growth Rate (2014-2019)
Figure Global Embolization Particles Revenue Growth Rate (2014-2019)
Table Global Novel Drug Delivery Systems in Cancer Therapy Revenue by Application (2014-2019)
Table Global Novel Drug Delivery Systems in Cancer Therapy Revenue Share by Application (2014-2019)
Figure Global Novel Drug Delivery Systems in Cancer Therapy Revenue Share by Application (2014-2019)
Figure Global Novel Drug Delivery Systems in Cancer Therapy Revenue Share by Application in 2019
Table Global Novel Drug Delivery Systems in Cancer Therapy Revenue Forecast by Application (2019-2024)
Figure Global Novel Drug Delivery Systems in Cancer Therapy Market Share Forecast by Application (2019-2024)
Figure Global Hospitals & Clinic Revenue Growth Rate (2014-2019)
Figure Global Cancer Treatment Centers Revenue Growth Rate (2014-2019)
Figure Global Others Revenue Growth Rate (2014-2019)
Figure Global Novel Drug Delivery Systems in Cancer Therapy Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Novel Drug Delivery Systems in Cancer Therapy Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Novel Drug Delivery Systems in Cancer Therapy Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Novel Drug Delivery Systems in Cancer Therapy Revenue Market Forecast (2019-2024)
Figure Europe Novel Drug Delivery Systems in Cancer Therapy Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Novel Drug Delivery Systems in Cancer Therapy Revenue Market Forecast (2019-2024)
Figure South America Novel Drug Delivery Systems in Cancer Therapy Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Novel Drug Delivery Systems in Cancer Therapy Revenue Market Forecast (2019-2024)
※본 조사보고서 [세계의 암 치료용 신규 약물 전달 시스템 시장 2019 : 기업별, 지역별, 종류/용도별, 시장예측] (코드 : GIR9090580) 판매에 관한 면책사항을 반드시 확인하세요.
※본 조사보고서 [세계의 암 치료용 신규 약물 전달 시스템 시장 2019 : 기업별, 지역별, 종류/용도별, 시장예측] 에 대해서 E메일 문의는 여기를 클릭하세요.